newsfilter
← Latest News
Business Wire·

Zura Bio to Participate in Two Upcoming Investor Conferences in November

Zura Bio Limited (NASDAQ:ZURA) ("Zura Bio"), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today announced that members of its senior